Major Study Links Flu Shot to 440% Surge in Pneumonia and Other Respiratory Illnesses

Flu-vaccinated individuals face sharply higher rates of pneumonia and other non-flu respiratory illnesses compared to the unvaccinated, according to multiple peer-reviewed studies.

While the flu shot may slightly reduce influenza itself, multiple studies prove that susceptibility to other infections is increased, a phenomenon known as viral interference or pathogenic priming.

In some cases, researchers observed illness rates more than four times higher in flu-vaccinated groups compared to the unvaccinated.

The study most often referenced is a 2012 randomized controlled trial led by epidemiologist Benjamin Cowling. It found that children who received the inactivated flu vaccine experienced a 4.4-fold increase in non-influenza respiratory infections, including viruses associated with pneumonia and coronaviruses.

While the authors stopped short of declaring causation, critics argue the findings point to a real immune trade-off—protection against one virus at the expense of broader respiratory resilience. A Cochrane Review examining flu vaccines acknowledged similar signals, though it framed the evidence cautiously.

Those concerns intensified after a U.S. Department of Defense analysis of the 2017–2018 flu season reported that vaccinated service members had a 36 percent higher risk of coronavirus infection than those who skipped the shot.

Robert F. Kennedy Jr. has repeatedly cited this research in blunt terms. “In a million years, I would not take the flu shot,” he has said, arguing that the vaccine primes the immune system in ways that may worsen outcomes when exposed to other pathogens.

For Kennedy and others, the pneumonia and coronavirus data are not side notes—they are the central issue.

Critics also question what’s inside the injection itself. Depending on formulation, flu vaccines may involve residual formaldehyde from manufacturing, thimerosal in some multi-dose vials, emulsifiers such as polysorbate 80, trace antibiotics like neomycin, and proteins from egg or animal cell lines.

Some versions use squalene-based adjuvants designed to intensify immune response, which critics controversially link to autoimmune reactions seen in Gulf War veterans. Regulators insist these components are safe at approved levels, but opponents argue long-term and cumulative effects remain poorly understood.

Adverse event data adds another layer of controversy. The U.S. Vaccine Adverse Event Reporting System contains hundreds of thousands of flu-vaccine-associated reports over time, including hospitalizations.

Supporters of flu vaccination emphasize reduced influenza severity and hospitalization at the population level. Critics respond that this framing glosses over individual immune differences and minimizes evidence suggesting that suppressing one virus may cause others—including more serious viruses— to explode in number.

Whether one agrees with RFK Jr. or not, the studies debunk the mainstream idea that the flu shot is a simple, consequence-free intervention.